Heron Therapeutics, Inc.
HRTX
$2.48
$0.093.77%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.66M | -4.85M | -9.24M | -3.16M | -10.72M |
| Total Depreciation and Amortization | 581.00K | 581.00K | 641.00K | 689.00K | 715.00K |
| Total Amortization of Deferred Charges | 300.00K | 377.00K | 144.00K | 140.00K | 163.00K |
| Total Other Non-Cash Items | 2.02M | 3.01M | 7.27M | 2.91M | 3.90M |
| Change in Net Operating Assets | -18.34M | 4.25M | -3.42M | -10.09M | 8.40M |
| Cash from Operations | -11.78M | 3.37M | -4.60M | -9.52M | 2.46M |
| Capital Expenditure | -638.00K | -431.00K | -637.00K | -- | -250.00K |
| Sale of Property, Plant, and Equipment | 27.00K | -- | -- | -- | 13.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.03M | 4.40M | 2.69M | 1.28M | -8.60M |
| Cash from Investing | 11.42M | 3.97M | 2.05M | 1.28M | -8.84M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 423.00K | 14.00K | 503.00K | -- | 201.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -11.00K | 11.00K | -2.00K |
| Cash from Financing | 423.00K | 14.00K | 492.00K | 11.00K | 199.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.00K | 7.36M | -2.06M | -8.23M | -6.18M |
